One of the fruitful results of oral technological advancement in dosage forms is the orally disintegrating tablets (ODTs) as they disintegrate rapidly in the mouth and do not require water for administration. This work employed mixture design approach for developing and optimizing oral disintegrating tablets of a slightly water soluble drug, vardenafil hydrochloride. Three component mixture design was used to optimize the type and concentration of superdisntegrants, crosscarmellose sodium (X 1 ), crosspovidone (X 2 ) and sodium starch glycolate (X 3 ) using water soluble dextrates (Emdex of the ODTs. The lowest disintegration time, wetting time and t 90 were showed by ODTs formula composed of 1.72 % of crosscarmellose in combination with 4.28 % of crosspovidone. So, this formula was chosen as the optimized formula. Stability studies also showed that the optimized formula was stable under accelerated conditions. And, by comparing the selected formula with Prosolv ® ODT G2 as a ready ODT system, it showed faster disintegration time and higher dissolution rate. Hence, the best superdisintegrants to be used with the water soluble dextrates are crosspovidone in combination with crosscarmellose sodium.
INTRODUCTION
Over the past three decades, orally disintegrating tablets (ODTs) have gained considerable attention as a preferred alternative to conventional tablets and capsules due to better patient compliance (Ganesh and Deshpande 2011) . ODTs are solid dosage forms containing medicinal substances which disintegrate rapidly, usually in a matter of seconds, when placed on the tongue (Hirani et al. 2009 ). These dosage forms are of particular advantages in certain patient groups who have difficulty in swallowing such as pediatric, geriatric and psychiatric patients (Sastry et al. 2000 , Suresh et al. 2008 . ODTs are formulated in such a way that they disperse, dissolve, or disintegrate rapidly in oral cavity, allowing release of the medication from the dosage form without water. This attributed to rapid water absorption into the core of the tablets, rapid disintegration of tablets and dissolving water soluble tablet components which leads to rapid dissolution of the tablets (Velmurugan and Vinushitha 2010) . Dissolved medication either swallowed or subjected to pregastric absorption which may lead to increasing the rate and extent of drug absorption and may decrease hepatic metabolism (Van Arnum 2007) .
Three main manufacturing methods are used for the manufacturing of different technologies of ODTs. These methods are: freeze drying (Ghosh et al. 2011) , molding (Fu et al. 2004 ) and compression method (Wagh et al. 2010 ). To develop a rapidly disintegrating tablet with direct-compression method, it was necessary to find suitable excipients with good compressibility and disintegrating ability. Although the superdisintegrants primarily affect the rate of disintegration, when used at high concentrations, they can also affect mouth feel, tablet hardness, and friability. Thus, several factors must be considered when selecting a superdisintegrant (Abdelbary et al. 2009 ). The direct-compression tablet"s disintegration and dissolution are based on the single or combined action of disintegrants and water-soluble excipients. In many cases, the disintegrants have a major role in the disintegration/dissolution process of rapidly disintegrating tablets made by direct compression. The choice of a suitable type and an optimal amount of disintegrants is paramount for ensuring a high disintegration rate (Dobetti 2001) . The simultaneous presence of a disintegrant with a high swelling (or disintegrating) force, defined as ""disintegrating agent" and a substance with a low swelling force, defined as ""swelling agent," was claimed as the key factor for the rapid disintegration of a tablet, also offering satisfactory physical resistance (Cousin et al. 1995) .
ODTs formulations have the advantages of both solid and liquid dosage forms and are useful for immediate release of drug with improved bioavailability enabling reduction of the therapeutic dose with almost the same pharmacological action; as higher doses from conventional dosage forms, and decreasing the adverse effects (Mostafa et al. 2013) .
Vardenafil is an oral therapy for the treatment of erectile dysfunction. It is a selective inhibitor of cyclic guanosine monophosphate (cGMP) specific phosphodiesterase type 5 (PDE5) which is the most abundant PDE in the human corpus cavernosum (DrugBank 2016).
A mixture design approach was used to optimize the type and concentration of superdisintegrants in developing using water soluble filler (dextrates). Simplex centroid mixture design was applied to optimize the concentration of crosscarmellose sodium (X 1 ), crosspovidone (X 2 ) and sodium starch glycolate (X 3 ). Special cubic model with interaction terms was derived to evaluate the effect of the three components on ODTs disintegration time (Y 1 ), wetting time (Y 2 ) and time for 90 % release of the drug t 90 (Y 3 ). The effect of lower and higher superdisintegrant concentrations were also investigated for the optimized formula. Furthermore, the optimized formula was subjected to accelerated stability conditions and finally it was compared with Prosolv ® ODT G2 as a ready ODT system.
Materials and methods

Materials
Vardenafil hydrochloride (B.N: UT2130408, Exp: March 2018) was kindly supplied by Marcyrl (Obour City, Egypt). Dextrates (Emdex®), Sodium stearyl fumarate (Pruv®), crosscarmellose sodium (Vivasol®), sodium starch glycolate (Explotab®) and Prosolv® ODT G2 were kindly supplied by JRS (Aalen, Germany). Crosspovidone was received from Sigma for pharmaceutical Industries (Cairo, Egypt). Spray dried mannitol (MannogemTM EZ) was kindly supplied by SPI (Grand Haven, MI, USA).
Methods
Precompression parameters
Bulk Density
Apparent bulk density (ρb) was determined by pouring blend into a graduated cylinder. The bulk volume (Vb) and weight of powder (M) was determined. The bulk density was calculated using the formula (USP30-NF25 2007) ρb = M/Vb
(1)
Tapped Density
The measuring cylinder containing known mass of blend was tapped for a fixed time. The minimum vo-lume (Vt) occupied in the cylinder and weight (M) of the blend as measured. The tapped density (ρt) was calculated using the formula (USP30-NF25 2007)
Hausner ratio
Hausner ratio is an indirect index of ease of powder flow. It is calculated by the following formula (USP30-NF25 2007)
Hausner ratio = ρt/ρb
Where ρt is tapped density and ρb is bulk density. Lower hausner ratio (< 1.25) indicate better flow prop-erties than higher ones (>1.25).
Carr's index
The compressibility index of blend can be determined using Carr"s compressibility index, and can be determined by the following formula (USP30-NF25 2007):
Preformulation study by DSC DSC studies were carried out using (Shimadzu DTA-50 Analyzer, Kyoto, Japan) to check the compatibility of ingedients. DSC thermograms of pure drug (vardenafil hydrochloride), crosscarmellose sodium, crosspovidone, sodium starch glycolate, dextrates, mannitol and sodium stearyl fumarate were obtained. Approximately 5 mg of samples were weighed and placed in the aluminum pans and heated at a rate of 10 °C/min, with indium in the reference pan; in an atmosphere of nitrogen to a temperature 350 °C. The DSC studies were performed for vardenafil hydrochloride and physical mixture of vardenafil hydrochloride with the investigated excipients.
Experimental design
Three component simplex centroid mixture design was used to optimize crosscarmellose sodium, CCS (X 1 ), crosspovidone, CP (X 2 ) and sodium starch glycolate, SSG (X 3 ) concentrations using a statistical package (Design-Expert® Version 7.0.0). Binary and tertiary interaction terms were derived for the statistical models to evaluate the effect of the three components on ODTs disintegration time (Y 1 ), wetting time (Y 2 ) and time for 90 % drug release, t 90 (Y 3 A polynomial function is usually used to describe the response in a mixture experiment. This polynomial function represents how the components affect the response. To better study the shape of the response surface, the natural choice for a design would be the one whose points are spread evenly over the whole simplex. A simplex centroid design only includes the centroid points. Since a simplex centroid design usually has fewer runs than a simplex lattice design with the same degree, a polynomial model with fewer terms should be used. A simplex centroid design can be used to fit the following model. Y= β 1 X 1 + β 2 X 2 + β 3 X 3 + β 12 X 1 X 2 + β 13 X 1 X 3 + β 23 X 2 X 3 + B 123 X 1 X 2 X 3 (5)
The above model is called the special cubic model. The intercept term is not included due to the correlation between the three components (their sum is 100%). a Tablet weight = 100 mg
Tablet manufacturing
ODTs were manufactured by direct compression method. The composition of vardenafil hydrochloride OTDs tablet formulations is displayed in Table ( 3). The corresponding amounts of drug, filler (dextrates) and superdisintegrants (CCS, CP and SSG) were accurately weighed. The weighed powder excipients were transferred into Cube Mixer KB (Erweka, S2Y, Heusenstamm, Germany) and mixed for 5 min. Thereafter, the corresponding amount of mannitol was accurately weighed, added to the mixture and the powder mixture was further mixed for 10 min. The formula weight of sodium stearyl fumarate was mixed with the powder in the cube mixer for 2 min. Finally, the powder was compressed into tablets using Single stroke tablet compressing machine (Royal Artist, Mumbai, India) using 6-mm diameter rounded flat punches. The tablets were collected during compression for in-process testing (weight and hardness) and were stored in airtight high-density polyethylene (HDPE) bottles pending further testing (Mostafa, Ibrahim et al. 2013 ).
Weight variation
Twenty tablets from each batch were individually weighed and the average weight and standard deviation were reported (Rahman et al. 2012 ).
Hardness
Tablet hardness was determined using hardness tester PTB 311 (Pharma test GmbH, Hainburg, Germany) for 10 tablets of each batch with known weight. The average hardness and standard deviation were reported.
Friability
Tablet friability was determined according to (USP30-NF25 2007) . In brief, 20 tablets were weighed (W1) and placed into the Single drum automated friability tester (Pharma Test, Hainburg, Germany) that was rotated at 25 rpm for 4 min. The tablets then were reweighed after removal of fines (W2), and the friability was calculated by:
Content Uniformity
Uniformity of dosage unit was assessed according to (USP30-NF25 2007) requirements. Twenty tablets were randomly selected and average weight was calculated and powdered in a glass mortar. Powder equivalent to 11.85 mg of drug was weighed and dissolved in 100 ml of 6.8 pH phosphate buffer, filtered and drug content analyzed using UV spectrophotometer (Shimadzu 1800 dual beam, Kyoto, Japan) at a wavelength of 215 nm. The drug concentration was measured using the constructed standard calibration curve.
In vitro disintegration time
In vitro disintegration test was assessed according to the (USP30-NF25 2007) requirements for immediate release tablets. One dosage unit was put in each of the six tubes of the basket. The apparatus (Pharmatest PTZ 3E, Hainburg, Germany) was operated, using distilled water as the immersion fluid, maintained at 37 ± 2°C. Time for complete disintegration of each table and standard deviation were calculated (Shoukri et al. 2009 ).
In vitro dissolution studies
In vitro drug release was performed for vardenafil hydrochloride tablets according to the (USP30-NF25 2007) "Dissolution procedure" for immediate release dosage forms. A minimum of 6 tablets of each formula were tested. The USP 30 (apparatus 2) paddle method was used. Dissolution was carried out in 500 ml phosphate buffer pH 6.8 ± 0.05 to simulate saliva fluid. The paddle was rotated at 50 rpm at 37 ± 0.5 ºC. Samples were tested at specified time intervals (0.5, 1, 1.5, 2, 3, 4, 5, 6, 8, 10, 15, 20, 25 and 30 min) . Samples were adequately diluted and analyzed spectrophotometrically at wavelength 215 nm.
Wetting time and wetting ratio
Ten milliliters of distilled water containing eosin, a water soluble dye, were placed in a Petri dish of 10 cm diameter containing circular tissue papers of 10 cm diameter. One tablet carefully placed in the center of the Petri dish and the time required for water to reach the upper surface of the tablet was noted as the wetting time. The test results are presented as mean value of three determinations ± SD (Jonwal et al. 2010) . The complete wetted tablet was then weighed. Water absorption ratio, R, was determined according to the following equation:
Where W b and Wa are tablet weights before and after water absorption, respectively.
Stability study of the optimized ODTs formula
In order to investigate effect of storage on the optimized formula, accelerated stability study was carried out at 40 ± 2 ºC in a humidity chamber having 75 ± 5 % RH. Samples were withdrawn after three months and evaluated for change in drug content, hardness and disintegration time. Also, the kinetic parameters were calculated.
Comparing the optimized ODTs formula with Prosolv
® ODT as a ready ODT system.
The optimized vardenafil hydrochloride ODTs formula was compared to Prosolv ® ODT G2, a ready ODT system. Table (4) represents ODTs formula prepared by Prosolv ® ODT. Prosolv ® ODT G2 is composed of microcrystalline cellulose, colloidal silicon dioxide, mannitol, fructose and crospovidone manufactured using JRS Pharma's coprocessing technology. It is a high functionality excipient for orally disintegrating tablet formulation, development, and manufacture. Disintegration time, wetting time, t 90 and dissolution profiles were evaluated for both optimized formula and Prosolv ® ODT. DSC thermogram of vardenafil hydrochloride showed sharp endothermic peak at 227 ºC corresponding to its melting point which indicates its crystallinity and purity, Figure ( 1.a) (DrugDetails 2016). DSC thermogram of crosscarmellose sodium, crosspovidone and sodium starch glycolate (Jagadish et al. 2010) , Figures (1.b, 1 .c and 1.d) showed broad endotherm at 64.68 ºC, 60.33 ºC and 63.56 ºC respectively due to melting whereas during scanning of Emdex ® , endothermic peaks at 86.69 ºC, 148.64 ºC and 220.70 ºC were observed, (Figure 1 .e). DSC thermogram of mannitol showed endothermic peak at 169.11 ºC, while DSC of sodium stearyl fumarate showed three endothermic peaks at 101.05 ºC, 139.14 ºC and 201 ºC and an exothermic peak at 246 ºC, Figures (1.f and 1.g ), respectively.
As shown in figure (1) , Physical mixture of each ingredient with drug showed their identical peaks at defined temperature range. Presence of all peaks indicates that all ingredients are compatible with drug. 
Data obtained from experimental design
All tablet formulations were prepared according to the matrix of the design (Table  2 ) and according to formulae mentioned in Table ( 3). Vardenafil hydrochloride ODTs properties (weight, hardness, hausner ratio, carr's index, wetting time, wetting ratio and drug content) are summarized in Table ( 5) and the responses measured (disintegration "Y 1 ", wetting time "Y 2 " and time for 90% drug release "Y 3 ") are summarized in Figure  ( 2). All manufactured tablets formulations met the USP30-NF25 requirements for uniformity of dosage units. Acceptance values of all formulations were within the USP30-NF25 limit and drug content was ranged from 98.21 ± 0.841 % to 102.82 ± 1.162 %. Furthermore, all tablets friability was below 0.577 % which compiles with USP requirements. Disintegration time, wetting time and t 90 values for all the ten formulations ( Figure 2) The above equations were derived by the best-fit method to describe the main effect of process variables (X 1 , X 2 and X 3 ) and their interaction (X 1 X 2 , X 1 X 3 , X 2 X 3 and X 1 X 2 X 3 ) on the responses (Y 1 , Y 2 and Y 3 ). The values of the coefficients (regression coefficient) are associated with the effect of these variables on the response. Coefficients with more than one factor represent an interaction effect of two factors (e.g. X 1 X 2 , X 1 X 3 and X 2 X 3 ) while interaction of the three components (e.g. X 1 X 2 X 3 ) represent special cubic relationships. A positive sign reflects a synergistic effect while a negative sign stands for an antagonistic effect. It can be concluded, from all regression equations 8-10 and figure (3) that the special cubic interaction effect (X 1 X 2 X 3 ) had a great significant (p-value < 0.05) effect on disintegration time (Y 1 ). Also, it had a great insignificant antagonistic effect on wetting time (Y 2 ) with minor effect on t 90 (Y 3 ). Interaction effect (X 1 X 2 ) had a great significant antagonistic effect on disintegration time (Y 1 ) and t 90 (Y 3 ) with little effect on wetting time (Y 2 ) as the interaction effect (X 2 X 3 ) had the highest effect on it more than the other binary interactions. Moreover, interaction effect (X 2 X 3 ) had a noticeable significant antagonistic effect on t 90 (Y 3 ) and disintegration time (Y 1 ), while, (X 1 X 3 ) had insignificant effect on all responses. According to the individual variables X 1 had the highest synergistic effect on the three responses and X 2 had the least effect.
Analysis of fitted data
Response surface plots (Figure 4) are graphically representing the regression equations 3-5 showing the effect of CCS (X 1 ), CP (X 2 ) and SSG (X 3 ) on the disintegration time, wetting time and T 90 of vardenafil hydrochloride ODTs. By visual observation of the plots, it can be seen that they nearly have the same pattern indicating a marked decrease in disintegration time, wetting time and t 90 by increasing the concentration of CP and reached their minimum values at a concentration around 4.24 %, thereafter, increase slightly to the concentration of 6 % of CP. This results are in accordance with Prajapati and Patel (Prajapati and Patel 2010) who studied the different behavior of wetting time, in-vitro disintegration time and cumulative % drug released of piroxicam ODTs prepared by different superdisintegrants using water soluble filler (Mannitol). They concluded that the crospovidone can be successfully utilized for preparation of ODTs. This may be due to crospovidone swell by 95% to 120% upon contact with water; in addition, during tablet compaction the highly compressible crosspovidone particles become extremely deformed. As the deformed crosspovidone particles come in contact with water that is wicked into the tablet, the particles recover their normal structure and then swell, resulting in rapid volume expansion and high hydrostatic pressures that cause tablet disintegration (Balasubramaniam et al. 2008) . Moreover, Zade, Kawtikwar et al. investigated the effect of type and concentration of the disintegrants (Croscarmellose Sodium, Sodium starch glycolate and crospovidone) on tizanidine ODTs properties. They concluded that tablets prepared using 5 % of crosspovidone had the least disintegration time among tablets prepared by direct compression method (Zade et al. 2009 ). On the other hand CCS showed increased disintegration time and wetting time due to it works mainly by wicking mechanism and according to Lopez-Solıs and Villafuerte-Robles high hygroscopic disintegrants will be inhibited by other high water consuming formula components (e.g. dextrates) (Lopez-Solıs and Villafuerte-Robles 2001). Besides, water soluble fillers causes increase in viscosity of the penetrating fluids which tends to reduce effectiveness of disintegrating agents and as they are water soluble, they are likely to dissolve rather than disintegrate (Gopinath et al. 2012 ).
Figure (5) represent the in vitro dissolution profiles of vardenafil hydrochloride from different ODTs formulations. It can be seen that the formula 4, 6 and 7 showed the fastest dissolution profiles as they released the highest drug concentration after 3 minutes followed by formula 2 and 9 which showed slower dissolution rate giving the maximum drug dissolution after 4 and 5 minutes respectively. Formulations 1, 3, 5, 8 and 10 showed the lowest dissolution rate (66.78 %, 65.46 %, 73.34 %, 83.21 and 86 .40 %) respectively, after 5 minutes. These results are in accordance with Battu, Repka et al who studied the effect of varying concentrations of different superdisintegrants on disintegration time and in vitro dissolution profiles of different rapidly disintegrating fenoverine tablets. They found that release of drug was faster from formulations containing 6 % crospovidone compared to other formulations (Battu et al. 2007 ). 
Stability study of the optimized ODTs formula
The optimized formula was selected for studying the effect of storage on tablet physical properties and drug release. Figure (7) showed the disintegration time and hardness of the optimized ODTs formula before and after storage under accelerated conditions for three months. Also, table (7) showed the percent remained of vardenafil hydrochloride from the selected formulation after storage at 40 ± 2 O C and 75 ± 5 %, relative humidity.
It is clear from Figure (7) that the disintegration time of the selected formula was not significantly affected by storage under accelerated conditions. On the other hand, the hardness was significantly increased from 2.25 ± 0.058 Kp to 2.77 ± 0.071 Kp. Those results are in accordance with shukla and price who studies the effect of moisture content on the crushing force of dextrates. They found that dextrates crushing force was increased dramatically by increasing the moisture content due to the moisture improves bonding between particles of dextrates (Shukla and Price 1991) . Moreover, Table (7) showed that the percent remained of vardenafil hydrochloride after 90 days was 98.28 % and by calculating the kinetic parameters it is obvious that the degredation of vardenafil hydrochloride was zero order reaction based on the values of correlation coefficient (r) and the t 90 for the optimized formula was 1.52 years (Samy et al. 2001), table (8) . Comparing the optimized ODTs formula with Prosolv ® ODT as a ready ODT system Figure (8) showed the properties of both optimized and Prosolv ® ODT tablets. It is clear from the figure that the optimized ODTs formula had a very significant lower disintegration time, wetting time and t 90 . Additionally, it was clear from the dissolution profiles of both formulations that the optimized formula gave significant higher dissolution rate than Prosolv ® ODT Figure ( 
Conclusion
Vardenafil hydrochloride ODTs were successfully prepared using direct compression method. The composition of ODTs could be optimized using a simplex centroid mixture design so as to obtain rapid disintegration, wettability and drug dissolution along with acceptable tablets hardness and friability. Furthermore, the stability study results of optimized batch indicate that there is no alteration after storage. Also, by comparing the optimized formula with Prosolv ® ODT it showed significant lower disintegration time and higher dissolution rate. This could enhance drug absorption and bioavailability with a rapid onset of action, resulting in improved patient compliance and convenience. It can be concluded from the results of the optimization study that ODTs containing water soluble filler and binder like dextrates and mannitol can be formulated successfully using superdisintegrants crospovidone in combination with crosscarmellose sodium.
